Children and young people should routinely be offered the opportunity to participate in and to benefit from medical research.
Children and young people should routinely be offered the opportunity to participate in and to benefit from medical research, according to updated guidance from the UK Royal College of Pediatrics and Child Health.
The guidelines provide updated practical information on ethical issues in relation to research involving children, aimed at research councils. It reflects many of the changes that have taken place with regards to EU regulations over the last 14 years. The key principles include:
“Children require protection, but this should not preclude the claim of other rights, including the right to the highest standard of healthcare, to be informed, express their views, and influence decisions made about them,” said lead author Neena Modi, MD, Professor of Neonatal Medicine at Imperial College London. “The more robust research we can conduct, the greater the likelihood of developing new treatments and procedures that will greatly improve healthcare for children and young people.”
The guidelines also emphasize the importance of involving children, young people and parents in all aspects of medical research—from prioritization to development and dissemination. Overall, they reflect current regulations and should help researchers make the right decisions about child health research in the best interest of the child, she added.
The guidance was published in an online article posted on June 9 by
Archives of Disease in Childhood
. To access the full article,
click here
.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.